Sourcebio International PLC
LSE:SBI

Watchlist Manager
Sourcebio International PLC Logo
Sourcebio International PLC
LSE:SBI
Watchlist
Price: 115 GBX 4.55% Market Closed
Market Cap: 78.4m GBX
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

SBI Price Targets Summary
Sourcebio International PLC

There are no price targets for SBI.
SBI Lowest Forecast
Wall Street Target
Not Available
SBI Average Forecast
Wall Street Target
Not Available
SBI Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Sourcebio International PLC Competitors:
Price Targets
T
TALK
Talkspace Inc
84% Upside
CCRN
Cross Country Healthcare Inc
44% Upside
E
1846
Euroeyes International Eye Clinic Ltd
111% Upside
OPCH
Option Care Health Inc
21% Upside
T
TALK
Talkspace Inc
84% Upside
CCRN
Cross Country Healthcare Inc
44% Upside
E
1846
Euroeyes International Eye Clinic Ltd
111% Upside
OPCH
Option Care Health Inc
21% Upside
PRDA
Prodia Widyahusada Tbk PT
5% Upside
ADUS
Addus Homecare Corp
21% Upside
AIRS
Airsculpt Technologies Inc
1% Downside
DNTL
dentalcorp Holdings Ltd
58% Upside

Revenue
Forecast

Revenue Estimate
Sourcebio International PLC

For the last 3 years the compound annual growth rate for Sourcebio International PLC's revenue is 56%. The projected CAGR for the next 3 years is -19%.

56%
Past Growth
-19%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Sourcebio International PLC

For the last 3 years the compound annual growth rate for Sourcebio International PLC's operating income is 168%. The projected CAGR for the next 3 years is -31%.

168%
Past Growth
-31%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Sourcebio International PLC

The compound annual growth rate of Sourcebio International PLC's net income for the next 3 years is -35%.

N/A
Past Growth
-35%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
SBI intrinsic value, competitors valuation, and company profile.
DCF Valuation
SBI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SBI stock valuation using valuation multiples.
Wall Street Estimates
SBI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SBI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SBI's stock price target?
Not Available

SBI doesn't have any price targets made by Wall Street professionals.

What is Sourcebio International PLC's Revenue forecast?
Projected CAGR
-19%

For the last 3 years the compound annual growth rate for Sourcebio International PLC's revenue is 56%. The projected CAGR for the next 3 years is -19%.

What is Sourcebio International PLC's Operating Income forecast?
Projected CAGR
-31%

For the last 3 years the compound annual growth rate for Sourcebio International PLC's operating income is 168%. The projected CAGR for the next 3 years is -31%.

What is Sourcebio International PLC's Net Income forecast?
Projected CAGR
-35%

The compound annual growth rate of Sourcebio International PLC's net income for the next 3 years is -35%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 264,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.